【制药网 市场分析】近日,绿谷医药科技内部召开全国销售线上会议,宣布全国销售最后工作日定在 7 月 30 日,仅留小部分员工继续支持临床即时检验。这意味着绿谷在全国的 1000 多名员工中,近八成将面临裁员。绿谷此次裁员的直接原因是其核心产品 —— 阿尔茨海默病药物甘露特钠胶囊(编号 GV-971)的生产许可问题。971 的药品注册证于 2024 年 11 月 2 日到期,自那时起,该药物便不能...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.